Alejandra Droguett

Alejandra Droguett

Auto-generated profile, based on publicly available information

Alejandra Droguett

Nephrology Division, School of Medicine, Universidad Austral de Chile, Valdivia, Chile

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in Kidney International
Verified
Journal Article
Closed access
SMSergio A. Mezzano
Sergio A. Mezzano
MBMiguel Barría
Miguel Barría
MDM. Alejandra Droguett
M. Alejandra Droguett
MBM. Eugenia Burgos
M. Eugenia Burgos
Leopoldo G. ArdilesLeopoldo G. Ardiles
Leopoldo G. Ardiles
JEJesús Egido
Jesús Egido

1 October 2003 in Kidney International
Verified
Journal Article
Closed access
SMSergio Mezzano
Sergio Mezzano
ADAlejandra Droguett
Alejandra Droguett
MBM. Eugenia Burgos
M. Eugenia Burgos
Leopoldo G. ArdilesLeopoldo G. Ardiles
Leopoldo G. Ardiles
CFClaudio A. Flores
Claudio A. Flores
JEJesús Egido
Jesús Egido

1 January 2000 in Kidney International
Verified
Journal Article
Closed access
SMSergio A. Mezzano
Sergio A. Mezzano
MDM. Alejandra Droguett
M. Alejandra Droguett
MBM. Eugenia Burgos
M. Eugenia Burgos
Leopoldo G. ArdilesLeopoldo G. Ardiles
Leopoldo G. Ardiles
CAClaudio A. Aros
Claudio A. Aros
JEJesús Egido
Jesús Egido

1 June 2005 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
VDVincent Dolan
Vincent Dolan
MMMadeline Murphy
Madeline Murphy
DSDenise Sadlier
Denise Sadlier
DLDavid Lappin
David Lappin
PDPeter Doran
Peter Doran
HBHugh R. Brady
Hugh R. Brady

1 September 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MMMadeline Murphy
Madeline Murphy
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
BGBrenda Griffin
Brenda Griffin
JHJillian Howlin
Jillian Howlin
EMEmmett McArdle
Emmett McArdle
FMFinian Martin
Finian Martin
Induced in high glucose-1 (IHG-1) is an evolutionarily conserved gene transcript upregulated by high extracellular glucose concentrations, but its function is unknown. Here, it is reported that the abundance of IHG-1 mRNA is nearly 10-fold higher in microdissected, tubule-rich renal biopsies from patients with diabetic nephropathy compared with control subjects. In the diabetic nephropathy specimens, in situ hybridization localized IHG-1 to tubular epithelial cells along with TGF-β1 and activated Smad3, suggesting a possible role in the development of tubulointerstitial fibrosis. Supporting this possibility, IHG-1 mRNA and protein expression also increased with unilateral ureteral obstruction. In the HK-2 proximal tubule cell line, overexpression of IHG-1 increased TGF-β1–stimulated expression of connective tissue growth factor and fibronectin. IHG-1 was found to amplify TGF-β1–mediated transcriptional activity by increasing and prolonging phosphorylation of Smad3. Conversely, inhibition of endogenous IHG-1 with small interference RNA suppressed transcriptional responses to TGF-β1. In summary, IHG-1, which increases in diabetic nephropathy, may enhance the actions of TGF-β1 and contribute to the development of tubulointerstitial fibrosis.

15 September 2015 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
VMVanessa Marchant
Vanessa Marchant
ADAlejandra Droguett
Alejandra Droguett
GVGraciela Valderrama
Graciela Valderrama
MBM. Eugenia Burgos
M. Eugenia Burgos
DCDaniel Carpio
Daniel Carpio
SMSergio Mezzano
Sergio Mezzano
Diabetic nephropathy (DN) is currently a leading cause of end-stage renal failure worldwide. Gremlin was identified as a gene differentially expressed in mesangial cells exposed to high glucose and in experimental diabetic kidneys. We have described that Gremlin is highly expressed in biopsies from patients with diabetic nephropathy, predominantly in areas of tubulointerstitial fibrosis. In streptozotocin (STZ)-induced experimental diabetes, Gremlin deletion using Grem1 heterozygous knockout mice or by gene silencing, ameliorates renal damage. To study the in vivo role of Gremlin in renal damage, we developed a diabetic model induced by STZ in transgenic (TG) mice expressing human Gremlin in proximal tubular epithelial cells. The albuminuria/creatinuria ratio, determined at week 20 after treatment, was significantly increased in diabetic mice but with no significant differences between transgenic (TG/STZ) and wild-type mice (WT/STZ). To assess the level of renal damage, kidney tissue was analyzed by light microscopy (periodic acid-Schiff and Masson staining), electron microscopy, and quantitative PCR. TG/STZ mice had significantly greater thickening of the glomerular basement membrane, increased mesangial matrix, and podocytopenia vs. WT/STZ. At the tubulointerstitial level, TG/STZ showed increased cell infiltration and mild interstitial fibrosis. In addition, we observed a decreased expression of podocin and overexpression of monocyte chemoattractant protein-1 and fibrotic-related markers, including transforming growth factor-β1, Col1a1, and α-smooth muscle actin. Together, these results show that TG mice overexpressing Gremlin in renal tubules develop greater glomerular and tubulointerstitial injury in response to diabetic-mediated damage and support the involvement of Gremlin in diabetic nephropathy.